Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
When researchers want to edit, activate, or silence a gene in any living organism, from bacteria to humans, they often turn to CRISPR/Cas9, a complex of RNA and protein that can act like a genetic Swiss Army Knife.
Many people struggle to keep their weight in check as they get older. Now new research at Karolinska Institutet has uncovered why that is: Lipid turnover in the fat tissue decreases during ageing and makes it easier to gain weight, even if we don’t eat more or exercise less than before. The study is published in the journal Nature Medicine.
Parasitic worm infections can reduce the susceptibility of immune cells to HIV infection, according to new University of Liverpool research.
A novel CAR T-cell therapy, developed by UCL researchers and designed to target cancer cells more quickly and cause fewer side effects, has shown very promising results for children with previously incurable acute lymphoblastic leukaemia (ALL).
Impact statement: New technology that recreates some of the complexity of the human retina may help scientists study eye disease and screen for drug side effects that harm the eye.